Gene · 5378
Papers1,886
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 1,886
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comprehensive Analysis of Co-Mutations Identifies Cooperating Mechanisms of Tumorigenesis. | Cancers (Basel) | 2022 | 35053577 | PubTator, text mining | PubMed |
| A whole-exome case-control association study to characterize the contribution of rare coding variation to pancreatic cancer risk. | HGG Adv | 2022 | 35047863 | PubTator, text mining | PubMed |
| Genomic Correlates of Unfavorable Outcome in Locally Advanced Cervical Cancer Treated with Neoadjuvant Chemoradiation. | Cancer Res Treat | 2022 | 35038823 | PubTator, text mining | PubMed |
| DNA damage in preimplantation embryos and gametes: specification, clinical relevance and repair strategies. | Hum Reprod Update | 2022 | 35021196 | PubTator, text mining | PubMed |
| Genetic Analysis Reveals the Prognostic Significance of the DNA Mismatch Repair Gene MSH2 in Advanced Prostate Cancer. | Cancers (Basel) | 2022 | 35008387 | PubTator, text mining | PubMed |
| Exonic variants in multiple myeloma patients associated with relapsed/ refractory and response to bortezomib regimens. | Saudi J Biol Sci | 2022 | 35002457 | PubTator, text mining | PubMed |
| COL17A1 germline variant p.Ser1029Ala and mucosal malignant melanoma: An autopsy study. | Mol Clin Oncol | 2022 | 34987801 | PubTator, text mining | PubMed |
| Genomic Features of Muscle-invasive Bladder Cancer Arising After Prostate Radiotherapy. | Eur Urol | 2022 | 34953602 | PubTator, text mining | PubMed |
| Application of Multigene Panel Testing in Patients With High Risk for Hereditary Colorectal Cancer: A Descriptive Report Focused on Genotype-Phenotype Correlation. | Dis Colon Rectum | 2022 | 34897210 | PubTator, text mining | PubMed |
| A phase 2 evaluation of pembrolizumab for recurrent Lynch-like versus sporadic endometrial cancers with microsatellite instability. | Cancer | 2022 | 34875107 | PubTator, text mining | PubMed |
| Investigation of discordant sibling pairs from hereditary breast cancer families and analysis of a rare PMS1 variant. | Cancer Genet | 2022 | 34852986 | PubTator, text mining | PubMed |
| Analysis of the MLH1, MLH2, MLH6, PMS2 genes and their correlations with clinical data in rectal mucinous adenocarcinoma. | Ann Ital Chir | 2022 | 34807001 | PubTator, text mining | PubMed |
| Implication and Influence of Multigene Panel Testing with Genetic Counseling in Korean Patients with BRCA1/2 Mutation-Negative Breast Cancer. | Cancer Res Treat | 2022 | 34793666 | PubTator, text mining | PubMed |
| Unboxing the molecular modalities of mutagens in cancer. | Environ Sci Pollut Res Int | 2022 | 34611806 | PubTator, text mining | PubMed |
| Lynch syndrome-associated lung cancer: pitfalls of an immunotherapy-based treatment strategy in an unusual tumor type. | Explor Target Antitumor Ther | 2021 | 36046437 | PubTator, text mining | PubMed |
| OPPORTUNISTIC SCREENING FOR COLORECTAL CANCER IN HIGH-RISK PATIENTS IN FAMILY MEDICINE PRACTICES IN THE REPUBLIC OF CROATIA. | Acta Clin Croat | 2021 | 35528152 | PubTator, text mining | PubMed |
| Evolution and Utility of Preimplantation Genetic Testing for Monogenic Disorders in Assisted Reproduction - A Narrative Review. | J Hum Reprod Sci | 2021 | 35197677 | PubTator, text mining | PubMed |
| Prevalence and Spectrum of Predisposition Genes With Germline Mutations Among Chinese Patients With Bowel Cancer. | Front Genet | 2021 | 35154239 | PubTator, text mining | PubMed |
| DNA Damage Repair: Predictor of Platinum Efficacy in Ovarian Cancer? | Biomedicines | 2021 | 35052761 | PubTator, text mining | PubMed |
| The Effect of Gene Mutations on Metastasis and Overall Survival in Metastatic and Nonmetastatic Colon Cancers. | Asian Pac J Cancer Prev | 2021 | 34967562 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5378/papers?page=21